Metabolomic Information Highly Useful for Predicting Future Prostate Cancer
A study by the Center’s Leo Cheng and colleagues suggests that metabolomic changes detected with an advanced nuclear magnetic resonance (NMR) spectroscopy technique can differentiate between patients with benign prostate biopsies who will or will not receive a prostate cancer diagnosis over the following years.



















